[RPIA Roster]
The Risk, Prevention and Intervention for Addictions [RPIA] Study Section reviews applications for research that aims to identify psychosocial and biological antecedents and risk pathways for the onset, development and progression of addictive behaviors across the lifespan as well as research leading to the development and testing of interventions to prevent or reduce onset, progression toward addiction, and continuation of addictive and related problem behaviors. Addictive and potentially addictive behaviors include, but are not limited to, the use or abuse of alcohol, tobacco, other licit and illicit drugs, and gambling. Domains of risk include biological, genetic, psychological, behavioral, cognitive, interpersonal, and environmental factors, at the individual and group levels in humans. Studies may address personality, temperament, genetic vulnerability, affect/motivation, family and social influences, co-occurring risk behaviors, co-morbidity, violence, victimization, social or economic disadvantage, and other factors pertaining to individuals, situations or social environment(s). Both qualitative and quantitative methods may be used.
Specific areas covered by RPIA:
- Studies of the etiology of substance abuse and other potentially addictive behaviors, across the life span.
- Studies of mechanisms and roles of affect, motivation, cognition, attitudes and intentions, personality and temperament, co-morbidity, exposure to addictive substances, family history, biological and genetic factors, social influences, stress, including trauma and victimization, socioeconomic status, neighborhood characteristics, and other factors that moderate or mediate relationships among addiction antecedents and individual outcomes.
- Studies of the acute effects of using substances.
- Studies of substance use onset and progression in individuals at high risk for addiction, including children of substance users and individuals in environments where drug use is prevalent.
- Studies of mechanisms underlying the transition to sustained substance use and frequent engagement in other addictive behaviors.
- Interpersonal and intrapersonal tobacco cessation interventions.
- Prevention of onset and progression toward addiction of tobacco and other licit and illicit substances, underage drinking, alcohol abuse and related problems.
- Studies of etiology, prevention and treatment for problem gambling and other addictive behaviors not involving substances across the life span.
RPIA has the following shared interests within the RPHB IRG:
-
With Psychosocial Development and Risk Prevention [PDRP]: Studies of psychosocial risk and interventions that address a wide array of risk behaviors, of which addiction is only one, may be reviewed by PDRP. Applications that address multiple risk behaviors with a primary interest in addictions may be reviewed in RPIA.
With Social Psychology, Personality and Interpersonal Processes [SPIP]: Studies with a primary focus on personality or social cognitive mechanisms and processes involved in addictive behaviors within interpersonal settings may be assigned to SPIP. When the primary focus is on addictive behaviors, RPIA may be more appropriate.
With Psychosocial Risk and Disease Prevention [PRDP]: Studies of smoking cessation to prevent or slow the progression of specific diseases may be assigned to PRDP. When the primary focus is on addictive behaviors, RPIA may be more appropriate.
RPIA has the following shared interests outside the RPHB IRG:
-
With the Health of the Population IRG [HOP]: Studies of the etiology, epidemiology, and consequences of addictive behaviors, as well as interventions to address them, at the population and community-levels [e.g., neighborhood, public policy] may be reviewed within HOP. Similarly, studies focused primarily on underlying genetic influences, e.g., those dealing with interactions between genetics and environment, endophenotypes, or genetic comorbidity between substance use and psychiatric disorder may be reviewed in HOP. Applications that focus on risk behavior and adaptive or maladaptive interpersonal processes, personality, motivation, or social cognitive processes, without major emphasis on macro-level influences, may be reviewed in RPIA. These may include studies with a genetic component within the context of a broader examination of the behavioral etiology of addictions. Studies of individual-level interventions may be reviewed within RPIA.
-
With the Biobehavioral and Behavioral Processes [BBBP] IRG: Studies of basic biobehavioral mechanisms of substance abuse may be reviewed within BBBP. These include basic biobehavioral mechanisms of conditioning, emotion and stress in humans and animals. When the biobehavioral mechanisms primarily concern addictive behaviors, RPIA may be more appropriate. Examples are underlying risk, initiation, progression and relapse of substance use and abuse primarily in humans. Studies that examine behavioral effects of prenatal exposure to addictive substances may be reviewed within BBBP. Studies focusing primarily on the development of substance use disorders in children of substance abusers could be reviewed in RPIA.
- With the AIDS and AIDS Related Research [AARR] IRG: Studies of HIV risk behaviors and interventions to modify those behaviors may be reviewed within AARR. Studies that focus primarily on risk for substance use and abuse and include HIV risk behaviors within the context of multiple high risk behaviors may be reviewed by RPIA. Studies that focus on HIV risk behaviors within substance abusing populations may be reviewed within AARR. Studies that describe or seek to modify HIV risk behaviors within the context of substance abuse prevention or treatment could be reviewed within RPIA.
- With the Integrative, Functional, and Cognitive Neuroscience [IFCN] IRG: Studies of the neural mechanisms underlying behavior related to the use of addictive substances may be reviewed within IFCN. Basic neuroscience approaches to motivation, emotion, and stress, primarily in animal models, may be reviewed in IFCN. When the focus is on psychosocial issues related to addictions in humans, RPIA could be more appropriate.
|
|